和元生物技术（上海）股份有限公司2025年第四次临时股东会决议公告

Meeting Overview - The fourth extraordinary general meeting of shareholders was held on November 13, 2025, in Shanghai [5] - The meeting was convened by the board of directors and chaired by Chairman Pan Yudong, utilizing a combination of on-site voting and online voting [2] Attendance - All 8 current directors attended the meeting, along with the board secretary and other senior management personnel [3] - The meeting complied with the relevant regulations of the Company Law and the company's articles of association [2][6] Voting Results - Two resolutions were presented: 1. Election of a non-independent director for the fourth board [4] 2. Change of an independent director for the fourth board [4] - Both resolutions were passed with more than half of the valid voting rights held by attending shareholders or their proxies [4] Legal Verification - The meeting was witnessed by Shanghai Jinmao Law Firm, with lawyers confirming that the meeting's procedures were in accordance with legal and regulatory requirements [6]